<?xml version="1.0" encoding="UTF-8"?>
<p>The management of public health is a major issue in the modern, industrial world, due to the rising pervasiveness of microbial resistance. Although numerous new antibiotics have been discovered and developed, multidrug-resistant bacteria are still becoming more prevalent and are creating a serious public health risk (
 <xref rid="B45" ref-type="bibr">Mohanty et al., 2017</xref>).Thus, there is a critical need to develop a new, powerful therapeutic approach to treat and kill Gram-negative, as well as Gram-positive, human pathogens. The biosynthesis and application of metal nanoparticles is now receiving great interest as a viable option due to its moderate success in being used to facilitate drug delivery (
 <xref rid="B62" ref-type="bibr">Zhang et al., 2008</xref>), treat chronic disease (
 <xref rid="B22" ref-type="bibr">Hong et al., 2008</xref>), and for its ability to treat bacterial infections in wounded tissues (
 <xref rid="B53" ref-type="bibr">Rai et al., 2009</xref>).
</p>
